Telling your healthcare providers about your medical history and the other medications you are taking is vital when considering any new medication
Consult qualified healthcare professionals before considering any peptide research
TB-500 is a synthetic version of Thymosin Beta-4 and is commonly explored for its potential systemic effects on healing, cellular migration, and overall recovery
Write it on the vial with a permanent marker
Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2